Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 607 Shares of Humana Inc. (NYSE:HUM)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS reduced its stake in Humana Inc. (NYSE:HUM) by 2.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,603 shares of the insurance provider’s stock after selling 607 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Humana were worth $6,496,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in HUM. Quest Partners LLC bought a new position in shares of Humana in the third quarter worth $701,000. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Humana in the third quarter worth $1,778,000. Moors & Cabot Inc. raised its position in shares of Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock worth $519,000 after buying an additional 40 shares in the last quarter. Landscape Capital Management L.L.C. raised its position in shares of Humana by 54.4% in the third quarter. Landscape Capital Management L.L.C. now owns 2,451 shares of the insurance provider’s stock worth $776,000 after buying an additional 864 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA raised its position in shares of Humana by 42.0% in the third quarter. Massachusetts Financial Services Co. MA now owns 391,657 shares of the insurance provider’s stock worth $124,053,000 after buying an additional 115,820 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Down 0.2 %

HUM opened at $266.33 on Friday. The company has a market cap of $32.14 billion, a P/E ratio of 26.77, a P/E/G ratio of 2.05 and a beta of 0.57. The business’s 50-day moving average price is $271.33 and its 200-day moving average price is $276.92. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. Humana’s payout ratio is presently 35.58%.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of recent analyst reports. Truist Financial increased their price objective on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Barclays increased their price objective on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. lowered their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Finally, StockNews.com downgraded Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, March 18th. Eighteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average target price of $285.68.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.37% of the stock is owned by insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.